CENTENE CORP - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations. - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Advertise
    • Contact
    • Editorial Staff
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
April 25, 2023 Newswires
Share
Share
Tweet
Email

CENTENE CORP – 10-Q – Management's Discussion and Analysis of Financial Condition and Results of Operations.

Edgar Glimpses
The following discussion of our financial condition and results of operations
should be read in conjunction with our consolidated financial statements and the
related notes included elsewhere in this filing. The discussion contains
forward-looking statements that involve known and unknown risks and
uncertainties.

                               EXECUTIVE OVERVIEW

General

We are a leading healthcare enterprise, committed to helping people live
healthier lives, with an established expertise in lower-income and medically
complex populations. We provide access to high-quality healthcare, innovative
programs, and a wide range of health solutions that help families and
individuals get well, stay well, and be well. We believe that our local approach
enables us to provide accessible, quality, culturally sensitive healthcare
coverage to our communities.

Results of operations depend on our ability to manage expenses associated with
health benefits (including estimated costs incurred) and selling, general and
administrative (SG&A) costs. We measure operating performance based upon two key
ratios. The health benefits ratio (HBR) represents medical costs as a percentage
of premium revenues, excluding premium tax revenues that are separately billed,
and reflects the direct relationship between the premiums received and the
medical services provided. The SG&A expense ratio represents SG&A costs as a
percentage of premium and service revenues, excluding premium taxes separately
billed.

Value Creation Plan

We established our Value Creation Plan to drive margin expansion by leveraging
our scale and generating sustainable, profitable growth. In addition to creating
shareholder value, this plan is an ongoing effort to modernize and improve how
we work in order to propel our organization to new levels of success and elevate
the member and provider experiences. During the first quarter of 2023, we
completed the following key milestones in our Value Creation Plan:

•Completed the divestitures of Magellan Specialty Health, Centurion, our prison
healthcare business, and HealthSmart, our third-party health plan administration
business.

•Completed $377 million of common stock repurchases in the first quarter of 2023
through our stock repurchase program, which were funded through divestiture
proceeds and free cash flow generated from operations. In addition, in April
2023, we completed an additional $200 million of common stock repurchases.

•Completed operating model changes initiated in 2022, including streamlining
call center management and utilization management.

•Initiated standardization of our pharmacy operating model.

•Launched our cloud-based, next-gen clinical population health platform.

Segments Update


In early 2023, and in conjunction with our updated strategic plan, executive
leadership realignment, and corresponding 2023 divestitures, we have revised the
way we manage the business, evaluate performance, and allocate resources,
resulting in an updated segment structure comprised of (1) a Medicaid segment,
(2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. We
began reporting under this new segment structure in 2023. Prior year information
has been adjusted to reflect the change in segment reporting.

Regulatory Trends and Uncertainties


The United States government, policymakers, and healthcare experts continue to
discuss and debate various elements of the United States healthcare model. We
remain focused on the promise of delivering access to high-quality, affordable
healthcare to all of our members and believe we are well positioned to meet the
needs of the changing healthcare landscape.

                                       18
--------------------------------------------------------------------------------
  Table of Contents
In contrast to previous executive and legislative efforts to restrict or limit
certain provisions of the Affordable Care Act (ACA), the American Rescue Plan
Act (ARPA), enacted in March 2021, contained provisions aimed at leveraging
Medicaid and the Health Insurance Marketplace to expand health insurance
coverage and affordability to consumers. The ARPA authorized an additional $1.9
trillion in federal spending to address the COVID-19 public health emergency
(PHE), and contained several provisions designed to increase coverage of certain
healthcare services, expand eligibility and benefits, incentivize state Medicaid
expansion, and adjust federal financing for state Medicaid programs, the
ultimate impact of which remain uncertain.

The ARPA initially enhanced eligibility for the advance premium tax credit for
enrollees in the Health Insurance Marketplace, which was extended through the
2025 tax year by the Inflation Reduction Act, enacted in August 2022.

In October 2022, the Treasury Department issued a final rule to address the
family glitch in the ACA, which relates to determining who is eligible for
premium subsidies. We see this as a significant step in making Marketplace more
affordable for working families.


The COVID-19 pandemic has impacted and may continue to affect our business. The
Families First Coronavirus Response Act, enacted in March 2020, increased
federal matching rates for state Medicaid programs with a requirement that
states suspend Medicaid redeterminations throughout the PHE. As a result, since
the onset of the PHE, our Medicaid membership has increased by 3.5 million
members (excluding new states North Carolina and Delaware and various state
product expansions or managed care organization changes). The Consolidated
Appropriations Act, 2023, signed into law on December 29, 2022, delinked the
Medicaid continuous coverage requirements from the PHE and, as a result, states
began Medicaid disenrollments on April 1, 2023. Per the Act, redeterminations
related to the PHE should be initiated within 12 months, by March 31, 2024, and
conclude during the second quarter of 2024. We are taking decisive action to
help ensure individuals take the state agency requested action to confirm
eligibility in their Medicaid coverage or find other appropriate coverage that
is best for themselves and their families. Our Ambetter Health product covers
the majority of our Medicaid states, and we believe we are among the best
positioned in the healthcare market to capture those transitioning coverage
through redeterminations. Although Medicaid continuous coverage requirements
were decoupled from the PHE, we are working to prepare for other provisions
still tied to the end of the PHE which expires May 11, 2023, including COVID
costs and coverage requirements, various other payment structures and electronic
prescribing of controlled substances.

We have more than three decades of experience, spanning seven presidents from
both sides of the aisle, in delivering high-quality healthcare services on
behalf of states and the federal government to under-insured and uninsured
families, commercial organizations, and military families. This expertise has
allowed us to deliver cost-effective services to our government partners and our
members. While healthcare experts maintain a focus on personalized healthcare
technology, we continue to make strategic decisions to accelerate the
development of new software platforms and analytical capabilities. We continue
to believe we have both the capacity and capability to successfully navigate
industry changes to the benefit of our members, customers, and shareholders.

First Quarter 2023 Highlights

Our financial performance for the first quarter of 2023 is summarized as
follows:

•Managed care membership of 28.5 million, an increase of 2.2 million members, or
8% year-over-year.

•Total revenues of $38.9 billion, representing 5% growth year-over-year.

•Premium and service revenues of $35.0 billion, representing 2% growth
year-over-year.

•HBR of 87.0%, compared to 87.3% for the first quarter of 2022.

•SG&A expense ratio of 8.6%, compared to 8.0% for the first quarter of 2022.

•Adjusted SG&A expense ratio of 8.5%, compared to 7.7% for the first quarter of
2022.

•Operating cash flows of $4.3 billion for the first quarter of 2023.

•Adjusted diluted earnings per share (EPS) of $2.11, compared to $1.83 for the
first quarter of 2022.

                                       19
--------------------------------------------------------------------------------
  Table of Contents
A reconciliation from GAAP diluted EPS to adjusted diluted EPS is highlighted
below, and additional detail is provided above under the heading "Non-GAAP
Financial Presentation":

                                                                  Three Months Ended March 31,
                                                                    2023                   2022
GAAP diluted EPS attributable to Centene                     $          2.04          $      1.44
Amortization of acquired intangible assets                              0.33                 0.34
Acquisition and divestiture related expenses                            0.04                 0.16
Other adjustments (1)                                                  (0.09)                   -
Income tax effects of adjustments (2)                                  (0.21)               (0.11)
Adjusted diluted EPS                                         $          2.11          $      1.83

(1) Other adjustments include the following pre-tax items:

2023:

(a) Magellan Specialty Health divestiture gain of $79 million, or $0.14 per
share ($0.12 after-tax) and real estate impairments of $26 million, or $0.05 per
share ($0.04 after-tax).

2022:

(b) Costs related to the PBM legal settlement of $2 million, or $0.00 per share
($0.00 after-tax).


(2) The income tax effects of adjustments are based on the effective income tax
rates applicable to each adjustment. In addition, the three months ended March
31, 2023, includes a one-time income tax benefit of $69 million, or $0.13 per
share, resulting from the distribution of long-term stock awards to the estate
of the Company's former CEO.

Current and Future Operating Drivers

The following items contributed to our results of operations as compared to the
previous year:


Medicaid

•In February 2023, our subsidiary, Buckeye Health Plan, commenced the Medicaid
contract awarded by the Ohio Department of Medicaid to continue servicing
members with quality healthcare, coordinated services, and benefits.

•In January 2023, our subsidiary, Delaware First Health, commenced its contract
for the statewide Medicaid managed care programs.


•In January 2023, our subsidiary, Louisiana Healthcare Connections, commenced
the Medicaid contract awarded by the Louisiana Department of Health to continue
administering quality, integrated healthcare services to members across the
state.

•In January 2023, our subsidiary, Managed Health Services, commenced the
contract awarded by the Indiana Department of Administration to continue serving
Hoosier Healthwise and Health Indiana Plan members with Medicaid and Medicaid
alternative managed care and care coordination services.

•In October 2022, the state of Ohio removed pharmacy services in connection with
the state's transition from managed care to a single pharmacy benefits
management (PBM).


•In July 2022, our subsidiary, Home State Health, commenced the MO HealthNet
Managed Care General Plan and Specialty Plan contracts. Under the General Plan,
Home State Health continues to serve multiple MO HealthNet programs including
Children's Health Insurance members and the state's newly implemented Medicaid
expansion population, across all regions of Missouri. Additionally, as the sole
provider of the newly awarded Specialty Plan, Home State Health now serves
approximately 53,500 foster children and children receiving adoption subsidy
assistance.

•Beginning in 2020, the federal government issued a PHE which suspended Medicaid
eligibility redeterminations. The ongoing suspensions, which were extended to
April 2023, have driven increased membership.
                                       20

--------------------------------------------------------------------------------

Table of Contents

Medicare

•Medicare membership declined year-over-year due to lower annual enrollment.

Commercial


•In 2023, our Health Insurance Marketplace product, Ambetter Health, expanded
into Alabama and extended its footprint by more than 60 counties across 12
existing states. In total, the Marketplace plan is available in more than 1,500
counties across 28 states. Additionally, Marketplace membership increased
year-over-year due to the expanded footprint, strong product positioning and
open enrollment results, as well as overall market growth.

Other

•In January 2023, we completed the divestitures of Magellan Specialty Health,
Centurion, our prison healthcare business, and HealthSmart, our third-party
health plan administration business.

•In December 2022, we completed the divestiture of Magellan Rx, which was part
of the Magellan Health, Inc. (Magellan) business acquired in January 2022.


•In November 2022, we completed the divestiture of our ownership stakes in our
Spanish and Central European businesses, including Ribera Salud, Torrejón Salud,
and Pro Diagnostics Group.

•In July 2022, we completed the divestiture of PANTHERx Rare (PANTHERx).

We expect the following items to impact our future results of operations:

Medicaid


•In April 2023, eligibility redeterminations related to the PHE began. These
redeterminations will extend over a 14-month period and are expected to conclude
in the second quarter of 2024. In addition to delinking the Medicaid continuous
enrollment provision from the PHE, the year-end spending bill also outlines key
coverage expansion provisions, including Children's Health Insurance Program
(CHIP) coverage. The provision requires states to provide 12 months of
continuous coverage for children under Medicaid and CHIP effective January 2024
and made the state option to extend coverage for postpartum women for up to 12
months permanent.

•In March 2023, the state of North Carolina passed legislation for Medicaid
Expansion, presenting a growth opportunity in our existing market.


•In December 2022, our subsidiary, Health Net of California, was selected by the
California Department of Health Care Services for direct Medicaid contracts in
10 counties, including Los Angeles (in which a portion will be subcontracted).
The contracts are anticipated to begin in January 2024.

•In September 2022, our subsidiary, Nebraska Total Care, was awarded the
Nebraska Department of Health and Human Services statewide Medicaid managed care
contract. Under the new contract, Nebraska Total Care will continue serving the
state's Medicaid Managed Care Program, known as Heritage Health. The new
contract term is five years and includes the option for two, one-year renewals.
The contract is anticipated to begin in January 2024, subject to the resolution
of third-party protests.

•In September 2022, our subsidiary, Superior HealthPlan (Superior), was awarded
a new, six-year contract by the Texas Health and Human Services Commission to
continue providing youth in foster care with healthcare coverage through the
STAR Health Medicaid program. Superior has been the sole provider of STAR Health
coverage since the program launched in 2008. The contract is anticipated to
begin in September 2023.

•In August 2022, our subsidiary, Magnolia Health Plan (Magnolia), was awarded
the Mississippi Division of Medicaid contract. Under the new contract, Magnolia
will continue serving the state's Coordinated Care Organization Program, which
will consist of the Mississippi Coordinated Access Network and the Mississippi
CHIP. The contract is anticipated to begin in July 2023, subject to the
resolution of third-party protests.

                                       21
--------------------------------------------------------------------------------
  Table of Contents
•In August 2021, our subsidiaries, Carolina Complete Health and WellCare of
North Carolina, were selected to coordinate physical and/or other health
services with Local Management Entities/Managed Care Organizations under the
state's new Tailored Plans. The Tailored Plans, which are expected to launch in
October 2023, are integrated health plans designed for individuals with
significant behavioral health needs and intellectual/developmental disabilities.

Medicare


•In October 2022, the Centers for Medicare and Medicaid Services (CMS) published
updated Medicare Star quality ratings for the 2023 rating year, which impacts
the 2024 revenue year. The decrease in Star quality ratings is driven by the
expiration of certain disaster relief provisions as well as deterioration in
select metrics. Over the past year, our leadership team launched a multi-year
plan to build and improve quality across the enterprise with a strong focus on
enhanced patient experience and access to care. We expect to begin to see the
results of these efforts with the 2024 rating year (2025 revenue year).

Other


•We continue to execute on Value Creation Plan initiatives including the award
of the new PBM contract commencing in 2024, portfolio review, real estate
optimization, stock and debt repurchases, along with an ongoing focus on quality
improvement actions. We expect these actions will drive future margin expansion,
create shareholder value, and improve the experience for our members and
providers.
                                       22

--------------------------------------------------------------------------------

Table of Contents

                                   MEMBERSHIP

From March 31, 2022 to March 31, 2023, we increased our managed care membership
by 2.2 million, or 8%. The following table sets forth our membership by line of
business:

                                                   March 31, 2023                 December 31, 2022                 March 31, 2022
Traditional Medicaid (1)                              14,521,100                      14,264,800                       13,590,100
High Acuity Medicaid (2)                               1,801,200                       1,710,000                        1,682,800
Total Medicaid (4)                                    16,322,300                      15,974,800                       15,272,900
Commercial Marketplace                                 3,093,600                       2,076,100                        2,031,000
Commercial Group                                         437,200                         441,100                          449,700
Total Commercial                                       3,530,800                       2,517,200                        2,480,700
Medicare (3) (4)                                       1,343,800                       1,511,100                        1,452,500
Medicare PDP                                           4,459,300                       4,226,000                        4,169,700
Total at-risk membership                              25,656,200                      24,229,100                       23,375,800
TRICARE eligibles                                      2,799,300                       2,832,300                        2,862,400
Total                                                 28,455,500                      27,061,400                       26,238,200

(1) Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health Insurance Program (CHIP), Foster Care, and Behavioral Health.
(2) Membership includes Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and
Supports (LTSS), and Medicare-Medicaid Plans (MMP) Duals.
(3) Membership includes Medicare Advantage and Medicare Supplement.
(4) Membership includes 1,323,000, 1,291,300, and 1,231,500 Dual Eligible Special Needs Plans (D-SNP) beneficiaries for the periods
ending March 31, 2023, December 31, 2022, and March 31, 2022, respectively.

                                       23

--------------------------------------------------------------------------------

Table of Contents

                             RESULTS OF OPERATIONS

The following discussion and analysis is based on our Consolidated Statements of
Operations, which reflect our results of operations for the three months ended
March 31, 2023 and 2022, prepared in accordance with generally accepted
accounting principles in the United States (GAAP).

Summarized comparative financial data for the three months ended March 31, 2023
and 2022 is as follows ($ in millions, except per share data in dollars):

                                                                           Three Months Ended March 31,
                                                                2023                  2022                 % Change
Premium                                                   $       33,825          $   31,889                         6  %
Service                                                            1,127               2,343                       (52) %
Premium and service revenues                                      34,952              34,232                         2  %
Premium tax                                                        3,937               2,953                        33  %
Total revenues                                                    38,889              37,185                         5  %
Medical costs                                                     29,434              27,838                         6  %
Cost of services                                                     870               1,988                       (56) %
Selling, general and administrative expenses                       3,011               2,745                        10  %
Depreciation expense                                                 142                 156                        (9) %
Amortization of acquired intangible assets                           183                 199                        (8) %
Premium tax expense                                                4,011               3,006                        33  %
Impairment                                                            20                   -                         n.m.

Earnings from operations                                           1,218               1,253                        (3) %
Investment and other income                                          353                  52                         n.m.
Debt extinguishment                                                    -                   3                         n.m.
Interest expense                                                    (180)               (160)                      (13) %

Earnings before income tax                                         1,391               1,148                        21  %
Income tax expense                                                   261                 296                       (12) %
Net earnings                                                       1,130                 852                        33  %
(Earnings) loss attributable to noncontrolling interests               -                  (3)                        n.m.

Net earnings attributable to Centene Corporation $ 1,130

       $      849                        33  %
Diluted earnings per common share attributable to Centene
Corporation                                               $         2.04          $     1.44                        42  %

n.m.: not meaningful




                                       24

--------------------------------------------------------------------------------

Table of Contents
Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022

Total Revenues

The following table sets forth supplemental revenue information for the three
months ended March 31, ($ in millions):

                                                   2023                   2022                   % Change
Medicaid                                     $       26,164          $     24,076                           9  %
Commercial                                            5,252                 4,132                          27  %
Medicare (1)                                          5,876                 5,757                           2  %
Other                                                 1,597                 3,220                         (50) %
Total Revenues                               $       38,889          $     37,185                           5  %

(1) Medicare includes Medicare Advantage, Medicare Supplement, D-SNPs, and Medicare Prescription Drug Plan
(PDP).




Total revenues increased 5% in the three months ended March 31, 2023 over the
corresponding period in 2022, driven by 52% membership growth in the Marketplace
business due to strong product positioning and open enrollment results, as well
as overall market growth; organic Medicaid growth, primarily due to the ongoing
suspension of eligibility redeterminations; and increased Medicaid premium tax
revenue. The decrease in Other revenue was driven by recent divestitures.

Operating Expenses

Medical Costs/HBR


The HBR for the three months ended March 31, 2023, was 87.0%, compared to 87.3%
in the same period in 2022. The HBR for the first quarter of 2023 was favorably
impacted by continued disciplined Marketplace pricing and lower utilization in
Medicare, partially offset by updated Medicaid return of premium payable revenue
estimates related to prior periods.

Cost of Services


Cost of services decreased by $1.1 billion in the three months ended March 31,
2023, compared to the corresponding period in 2022. The cost of service ratio
for the three months ended March 31, 2023, was 77.2%, compared to 84.8% in the
same period in 2022. The decreases were driven by recent divestitures.

Selling, General & Administrative Expenses


The SG&A expense ratio was 8.6% for the first quarter of 2023, compared to 8.0%
in the first quarter of 2022. The adjusted SG&A expense ratio was 8.5% for the
first quarter of 2023, compared to 7.7% in the first quarter of 2022. The
increases were driven by growth in the Marketplace business, which operates at a
higher SG&A ratio.

Impairment

During the first quarter of 2023, we recorded impairment charges of $20 million
for additional impairments related to our ongoing real estate optimization
initiatives, consisting of leased and owned real estate assets and related fixed
assets.

                                       25
--------------------------------------------------------------------------------
  Table of Contents
Other Income (Expense)

The following table summarizes the components of other income (expense) for the
three months ended March 31, ($ in millions):

                                                    2023        2022
                     Investment and other income   $ 353      $   52
                     Debt extinguishment               -           3
                     Interest expense               (180)       (160)
                     Other income (expense), net   $ 173      $ (105)



Investment and other income. Investment and other income increased by $301
million in the three months ended March 31, 2023 compared to the corresponding
period in 2022, driven by increased interest rates and the $79 million Magellan
Specialty Health divestiture gain.

Debt extinguishment. During the first quarter of 2022, we recognized an
immaterial gain related to the redemption of Magellan's outstanding Senior
Notes.


Interest expense. Interest expense increased by $20 million in the three months
ended March 31, 2023, compared to the corresponding period in 2022. The increase
was driven by increased interest rates.

Income Tax Expense


For the three months ended March 31, 2023, we recorded income tax expense of
$261 million on pre-tax earnings of $1.4 billion, or an effective tax rate of
18.8%. The effective tax rate for the first quarter of 2023 reflects the tax
effects of the distribution of long-term stock awards to the estate of the
Company's former CEO as well as the Magellan Specialty Health gain. For the
first quarter of 2023, our effective tax rate on adjusted earnings was 24.3%.
For the three months ended March 31, 2022, we recorded an income tax expense of
$296 million on pre-tax earnings of $1.1 billion, or an effective tax rate of
25.8%. For the first quarter of 2022, our effective tax rate on adjusted
earnings was 25.1%.

Older

Results of Operations and Financial Condition – Form 8-K

Newer

Report of the Supervisory Board for the financial year 2021

Advisor News

  • 2026 may bring higher volatility, slower GDP growth, experts say
  • Why affluent clients underuse advisor services and how to close the gap
  • America’s ‘confidence recession’ in retirement
  • Most Americans surveyed cut or stopped retirement savings due to the current economy
  • Why you should discuss insurance with HNW clients
More Advisor News

Annuity News

  • Guaranty Income Life Marks 100th Anniversary
  • Delaware Life Insurance Company Launches Industry’s First Fixed Indexed Annuity with Bitcoin Exposure
  • Suitability standards for life and annuities: Not as uniform as they appear
  • What will 2026 bring to the life/annuity markets?
  • Life and annuity sales to continue ‘pretty remarkable growth’ in 2026
More Annuity News

Health/Employee Benefits News

  • Hawaii lawmakers start looking into HMSA-HPH alliance plan
  • EDITORIAL: More scrutiny for HMSA-HPH health care tie-up
  • US vaccine guideline changes challenge clinical practice, insurance coverage
  • DIFS AND MDHHS REMIND MICHIGANDERS: HEALTH INSURANCE FOR NO COST CHILDHOOD VACCINES WILL CONTINUE FOLLOWING CDC SCHEDULE CHANGES
  • Illinois Medicaid program faces looming funding crisis due to federal changes
More Health/Employee Benefits News

Life Insurance News

  • Guaranty Income Life Marks 100th Anniversary
  • Delaware Life Insurance Company Launches Industry’s First Fixed Indexed Annuity with Bitcoin Exposure
  • Suitability standards for life and annuities: Not as uniform as they appear
  • Looking at Medigap supplements
  • What will 2026 bring to the life/annuity markets?
Sponsor
More Life Insurance News

- Presented By -

Top Read Stories

More Top Read Stories >

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Elevate Your Practice with Pacific Life
Taking your business to the next level is easier when you have experienced support.

ICMG 2026: 3 Days to Transform Your Business
Speed Networking, deal-making, and insights that spark real growth — all in Miami.

Your trusted annuity partner.
Knighthead Life provides dependable annuities that help your clients retire with confidence.

8.25% Cap Guaranteed for the Full Term
Guaranteed cap rate for 5 & 7 years—no annual resets. Explore Oceanview CapLock FIA.

Press Releases

  • ePIC Services Company and WebPrez Announce Exclusive Strategic Relationship; Carter Wilcoxson Appointed President of WebPrez
  • Agent Review Announces Major AI & AIO Platform Enhancements for Consumer Trust and Agent Discovery
  • Prosperity Life Group® Names Industry Veteran Mark Williams VP, National Accounts
  • Salt Financial Announces Collaboration with FTSE Russell on Risk-Managed Index Solutions
  • RFP #T02425
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Advertise
  • Contact
  • Editorial Staff
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet